Nicholas I Carruthers

This inventor holds 35 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Serotonin Receptor Modulators. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Johnson & Johnson Pharmaceutical Research & Development, LLC. Active years: 2002-2018.

USPTO Granted Patents = 35 (Patent Applications = 4)

% Patents Active = 71.4

CIPO Patents = 4

EPO Patents = 5

Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 103(Granted Patents)

Company Filing History:

20 out of 2,099

Janssen Pharmaceutica Nv

patents

11 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

1 out of 13

Johnson & Johnson Pharmaceutical Research & Development, LLC

patents

4. 3 out of 834,350

Other

patents

Years Active: 2002-2018

Loading Chart...

Areas of Expertise:

Serotonin Receptor Modulators

Heterocyclic Compounds

Neuropeptide Y2 Receptor

2-Aminopyrimidine Compounds

Non-Imidazole Aryloxyalkylamines

Phenyl-Substituted Imidazopyridines

Pyridine Compounds

Fused Heterocyclic Compounds

Naphthyridine Compounds

Non-Peptidic NPY Y2 Inhibitors

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9981909 - Serotonin receptor modulators (2018-05-29),

2. 8957059 - Modulators of serotonin receptors (2015-02-17),

3. 8829011 - 2-aminopyrimidine compounds as serotonin receptor modulators (2014-09-09),

4. 8642583 - Serotonin receptor modulators (2014-02-04),

5. 8575364 - Modulators of serotonin receptor (2013-11-05),

6. 8273762 - Hexahydro-pyrrolo-isoquinoline compounds (2012-09-25),

7. 8236792 - [object Object] (2012-08-07),

8. 8183239 - Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor (2012-05-22),

9. 8026242 - [object Object] (2011-09-27),

10. 7947718 - [object Object] (2011-05-24),

11. 7897771 - Fused heterocyclic compounds (2011-03-01),

12. 7754882 - Hexahydro-pyrrolo-isoquinoline compounds (2010-07-13),

13. 7687499 - [object Object] (2010-03-30),

14. 7645758 - Heterocyclic compounds (2010-01-12),

15. 7504426 - Heterocyclic compounds (2009-03-17),

Title: Nicholas I Carruthers: Pioneering Inventor Pushing the Boundaries of Innovation

Introduction: Nicholas I Carruthers, a visionary inventor based in Poway, CA (US), continues to shape the future with his relentless drive for innovation. With a remarkable legacy in the world of inventions, Carruthers's inventive solutions are paving the way for a better tomorrow.

Latest Patents: Carruthers has accumulated an impressive portfolio of 35 patents, with his latest groundbreaking inventions focusing on serotonin receptor modulators. These biphenyl compounds hold significant promise in the treatment of serotonin-mediated diseases, showcasing Carruthers's commitment to advancing healthcare solutions.

Career Highlights: Throughout his illustrious career, Carruthers has made significant contributions to companies such as Janssen Pharmaceutica Nv and Ortho-McNeil Pharmaceutical Corp. His expertise and innovative approach have been instrumental in driving research and development in the pharmaceutical industry, shaping the landscape of modern medicine.

Collaborations: Working alongside esteemed colleagues such as Chandravadan R Shah and Curt A Dvorak, Carruthers has fostered a culture of collaboration and excellence. Together, they have synergized their efforts to tackle complex scientific challenges and deliver cutting-edge solutions that benefit society as a whole.

Conclusion: Nicholas I Carruthers's dedication to pushing the boundaries of innovation, coupled with his passion for creating impactful inventions, solidifies his status as a pioneering inventor. His transformative work not only improves lives today but also inspires future generations to embrace creativity and drive positive change through innovation.